ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
ArrePath's investors include Insight Venture Management, LLC., Boehringer Ingelheim Venture Fund, Innospark Ventures, Viva BioInnovator, PTX Capital.
ArrePath is headquartered in Princeton, United States.
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
ArrePath is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ArrePath — Funding & Investors." VCBacked, June 23, 2025, https://www.vcbacked.co/company/arrepath. Accessed October 2, 2026.
VCBacked. (2025). ArrePath — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/arrepath
{{cite web |title=ArrePath — Funding & Investors |url=https://www.vcbacked.co/company/arrepath |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated